Ann: Company Update - COVID-19 To Accelerate Global Opportunities, page-21

WatchlistNotifications 1829My Account ForumsASX - By StockHMDAnn: Company Update - COVID-19 To Accelerate Global OpportunitiesHMDClick for more information6.67% 14.0¢Heramed LimitedAnn: Company Update - COVID-19 To Accelerate Global Opportunities24/03/20 09:41:51 Unwatch threadShareASX News 851 24/03/20 09:41 Post #: 43660810Release Date: 24/03/20 09:21Summary: Company Update - COVID-19 To Accelerate Global OpportunitiesPrice Sensitive: YesDownload Document 250.98KB8 Report ReplySharethecableguy7,384 Posts. 81 24/03/20 09:32 Post #: 43661092Spot light cometh..Here we go boys...Could be the start of our company building that extra zero on the m/c..Good luck to us all...TCGWhile we should note this is not a short-term revenue play, the potential is enormous...HMD Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held3 Report ReplyShareVegantacos937 Posts. 222 24/03/20 09:33 Post #: 43661122Oh gee, look at that - Telehealth solutions are in demand, and HMD is in a strong position to capitalise on that. Who would have thought?!? This is a health crisis, where the solution involves isolating people. Why on earth would you sell your telehealth stocks at a massive loss?As much as this whole situation is a complete mess, there’s a strong chance it’s a company maker for HMD. And the share price is under 6c. SMH.HMD Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held5 2 Report ReplySharethecableguy7,384 Posts. 81 24/03/20 09:37 Post #: 43661221Looks like they are running out of units to supply?"In order for HMD to answer the demand and business opportunities mentioned, the Company has expanded its efforts to solve supply chain challenges and utilise suppliers and manufacturers in Israel and globally. While having a fully operational supply chain remains a challenge, these efforts will assist the continuation of business discussions and operations while the Chinese supply chain slowly starts to come back."Ramping up global production? Nice...How can HeraMED assist: The Company has received a significant number of enquiries from leading insurance and healthcare providers globally regarding the rapid deployment and use of its HeraBEAT and HeraCARE platform and the Company has commenced discussion with these healthcare providers. HMD will update the market on the progress of these discussions when appropriate."David Groberman continues: “The outbreak of COVID-19 is having a considerably detrimental effect on our hospitals and healthcare providers. We have received an influx of enquiries from a large number of world leading healthcare providers and insurance companies regarding the deployment of our product, many of whom we had already commenced discussions with. The outbreak of COVID-19 has not only exponentially progressed many of these discussions but has also significantly fast-tracked testing and commercialisation of our offering.” "Might not spike today, but we're on our way...Just an opinion...TCGWhile we should note this is not a short-term revenue play, the potential is enormous...HMD Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held5 Report ReplyShareTricky2020752 Posts. 230 24/03/20 09:38 Post #: 43661243Of any company when you compare current size to scope of COVID opportunity HMD have a massive chance here to build a worldwide Telehealth company supporting social distancing. keeping pregnancies safe at home makes perfect sense.HMD Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held4